IL1B and gastroenteritis: Taken together, understanding the potential opposing roles of IL-1 agonists, such as IL-1α and IL-1β, during the initiation and progression of chronic intestinal inflammation, will shed further light on precise therapeutic modalities that will lead to more efficacious treatment of patients with IBD (Figure 3).